Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (scFv-CH3) contains two chains. The anti-EGFR scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-IGF1R scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Cervical cancer; Breast cancer; Pancreatic cancer therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-EGFR x Human Anti-IGF1R Bispecific Antibody (scFv-CH3) (BSFC-H324). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS